Skip to content
Open access · CC-BY via OpenAlex

Mesenchymal Stem Cell Therapy: Hope for Patients With Systemic Lupus Erythematosus

Aifen Li, Fengbiao Guo, Quanren Pan, Jiaxuan Chen, Hua-feng Liu, Qingjun Pan

Frontiers in Immunology · 2021 · ▲ 118 citations

Abstract

Systemic lupus erythematosus (SLE) is a chronic autoimmune disease. Although previous studies have demonstrated that SLE is related to the imbalance of cells in the immune system, including B cells, T cells, and dendritic cells, etc., the mechanisms underlying SLE pathogenesis remain unclear. Therefore, effective and low side-effect therapies for SLE are lacking. Recently, mesenchymal stem cell (MSC) therapy for autoimmune diseases, particularly SLE, has gained increasing attention. This therapy can improve the signs and symptoms of refractory SLE by promoting the proliferation of Th2 and Treg cells and inhibiting the activity of Th1, Th17, and B cells, etc. However, MSC therapy is also reported ineffective in some patients with SLE, which may be related to MSC- or patient-derived factors. Therefore, the therapeutic effects of MSCs should be further confirmed. This review summarizes the status of MSC therapy in refractory SLE treatment and potential reasons for the ineffectiveness of MSC therapy from three perspectives. We propose various MSC modification methods that may be beneficial in enhancing the immunosuppression of MSCs in SLE. However, their safety and protective effects in patients with SLE still need to be confirmed by further experimental and clinical evidence.

◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:

Read at source →

Provenance

Source
OpenAlex
DOI
10.3389/fimmu.2021.728190
Canonical
link ↗
Fetched
2026-10-31 MST

Cite this

APA
Li, A., Guo, F., Pan, Q., Chen, J., Liu, H., &amp; Pan, Q. (2021). Mesenchymal Stem Cell Therapy: Hope for Patients With Systemic Lupus Erythematosus. <em>Frontiers in Immunology</em>. https://doi.org/10.3389/fimmu.2021.728190
Vancouver
Li A, Guo F, Pan Q, Chen J, Liu H, Pan Q. Mesenchymal Stem Cell Therapy: Hope for Patients With Systemic Lupus Erythematosus. Frontiers in Immunology. 2021. doi:10.3389/fimmu.2021.728190.
BibTeX
@article{aifen2021Mesenc, title = {Mesenchymal Stem Cell Therapy: Hope for Patients With Systemic Lupus Erythematosus}, author = {Aifen Li and Fengbiao Guo and Quanren Pan and Jiaxuan Chen and Hua-feng Liu and Qingjun Pan}, journal = {Frontiers in Immunology}, year = {2021}, doi = {10.3389/fimmu.2021.728190}, }

Research neighborhood

References, citing works, and semantically nearest findings. Click a node to open it.

Related findings